CD19 and acute lymphoblastic leukemia: Peripheral blood flow cytometry revealed a marked increase in circulating B lymphoblasts (>75%) expressing CD10, CD19, CD20 (79%), CD22, CD38, and HLADR, suggestive of B-ALL (Table 1).